alpha 2-Antiplasmin (alpha 2-AP) is a major fibrinolysis inhibitor, whose complete, congenital absence has been found to be associated with a distinct hemorrhagic diathesis. We studied a 15-yr-old male with a hemorrhagic diathesis after trauma from early childhood on. This bleeding tendency was associated with a minimal alpha 2-AP level recorded functionally in the immediate plasmin inhibition test: less than or equal to 4% of normal. However, a normal plasma concentration of alpha 2-AP antigen (83%) was found. His sister (5 yr old) showed similar results (2 and 92%). In their family, eight heterozygotes could be identified by half-normal activity results and normal antigen concentrations. The inheritance pattern is autosomal recessive. On analysis, the alpha 2-AP of the propositus was homogeneous in all respects tested, suggesting a homozygous defect. We designated the abnormal alpha 2-AP as alpha 2-AP Enschede. alpha 2-AP Enschede showed the following characteristics: (a) complete immunological identity with normal alpha 2-AP; (b) normal molecular weight (sodium dodecyl sulfate-polyacrylamide gel electrophoresis); (c) normal alpha-electrophoretic mobility; (d) presence in plasma of both molecular forms excluding an excessive conversion to the less reactive non-plasminogen-binding form; (e) quantitatively normal binding to lys-plasminogen and to immobilized plasminogen kringle 1-3; and (f) normal Factor XIII-mediated binding to fibrin. Functional abnormalities were found in: (i) no inhibition of amidolytic activities of plasmin and trypsin, even on prolonged incubation; (ii) no formation of plasmin-antiplasmin complexes in plasma with plasmin added in excess; and (iii) no inhibition of fibrinolysis by fibrin-bound alpha 2-AP. In the heterozygotes, the presence of abnormal alpha 2-AP did not interfere with several functions of the residual normal alpha 2-AP. One-dimensional peptide mapping showed an abnormal pattern of papain digestion. We conclude that in this family, abnormal antiplasmin molecules, defective in plasmin inhibition but with normal plasminogen-binding properties, have been inherited. The residual plasminogen-binding properties do not protect against a hemorrhagic diathesis.
C Kluft, H K Nieuwenhuis, D C Rijken, E Groeneveld, G Wijngaards, W van Berkel, G Dooijewaard, J J Sixma
Title and authors | Publication | Year |
---|---|---|
Hemorrhagic disorders of fibrinolysis: a clinical review
JL Saes, SE Schols, WL van Heerde, MR Nijziel |
Journal of Thrombosis and Haemostasis | 2018 |
Role of heparin and non heparin binding serpins in coagulation and angiogenesis: A complex interplay
T Bhakuni, MF Ali, I Ahmad, S Bano, S Ansari, MA Jairajpuri |
Archives of Biochemistry and Biophysics | 2016 |
Assessment of Bleeding Risk in Patients with Cirrhosis
A Zanetto, M Senzolo, A Ferrarese, P Simioni, P Burra, KI Rodríguez-Castro |
Current Hepatology Reports | 2015 |
Reply
J Bommer, T Heinrich, H Heidt, V Hafner, E Jenetzky, I Walter-Sack, G Mikus |
Nephrology Dialysis Transplantation | 2008 |
α2-Antiplasmin and its deficiency: fibrinolysis out of balance
SL Carpenter, P Mathew |
Haemophilia | 2008 |
Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses
B Bouma, C Maas, BP Hazenberg, HM Lokhorst, MF Gebbink |
Journal of Thrombosis and Haemostasis | 2007 |
Antiplasmin
PB Coughlin |
FEBS Journal | 2005 |
The past, present and future of plasmin inhibitor
N Aoki |
Thrombosis Research | 2005 |
Lexikon der Syndrome und Fehlbildungen
R Witkowski, O Prokop, E Ullrich, G Thiel |
2003 | |
Affinity panning of peptide libraries using anti-streptokinase monoclonal antibodies: selection of an inhibitor of plasmin(ogen) active site
B Parhami-Seren, J Krudysz, P Tsantili |
Journal of Immunological Methods | 2002 |
Haemostatic abnormalities in patients with liver disease
T Lisman, FW Leebeek, PG de Groot |
Journal of Hepatology | 2002 |
Japanese Journal of Thrombosis and Hemostasis
M OKUDAIRA, H ASAKURA, Y SANO, Y SUGA, M YAMAZAKI, K AOSHIMA, E MORISHITA, M SAITO, Y ONTACHI, T MIZUTANI, M KATO, T ITO, K MIYAMOTO, S NAKAO |
Japanese Journal of Thrombosis and Hemostasis | 2001 |
Congenital alpha2-plasmin inhibitor deficiencies: a review
R Favier, N Aoki, P Moerloose |
British Journal of Haematology | 2001 |
Inactivation of the serpin α2-antiplasmin by stromelysin-1
HR Lijnen, BV Hoef, D Collen |
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology | 2001 |
Fibrinolytics and Antifibrinolytics
F Bachmann |
2001 | |
A Simple Screening Assay for Certain Fibrinolysis Parameters (FIPA)
TW Stief, F Hinz, J Kurz, MO Doss, V Kretschmer |
Thrombosis Research | 2000 |
The Influence of Developmental Haemostasis on the Laboratory Diagnosis and Management of Haemostatic Disorders During Infancy and Childhood
C Male, M Johnston, C Sparling, LA Brooker, M Andrew, P Massicotte |
Clinics in Laboratory Medicine | 1999 |
Hämostaseologie
G Müller-Berghaus, B Pötzsch |
Hämostaseologie | 1999 |
Laboratory Techniques in Thrombosis - a Manual
J Jespersen, RM Bertina, F Haverkate |
1999 | |
Severe Postadenoidectomy Bleeding Revealing Congenital alpha2 Antiplasmin Deficiency in a Child:
X Paqueron, R Favier, P Richard, J Maillet, I Murat |
Anesthesia & Analgesia | 1997 |
Criteria for a specific plasmin inhibition test (SPIT) in human plasma
P Meijer, C Kluft |
Fibrinolysis | 1996 |
Operative Treatment of Intramedullary Hematoma Associated with Congenital Deficiency of alpha sub 2 -Plasmin Inhibitor.: A Report of Three Cases*
Y Miyauchi, Y Mii, M Aoki, S Tamai, Y Takahashi, A Yoshioka |
The Journal of Bone and Joint Surgery. American volume. | 1996 |
Structural basis for serpin inhibitor activity
HT Wright, JN Scarsdale |
Proteins: Structure, Function, and Genetics | 1995 |
4 Pathophysiology of fibrinolysis
I Juhan-Vague, MC Alessi, PJ Declerck |
Baillière's Clinical Haematology | 1995 |
Pathophysiology of fibrinolysis
PJ Declerck, I Juhan-Vague, J Felez, B Wiman |
Journal of Internal Medicine | 1994 |
Thrombin, a Link between Coagulation Activation and Fibrinolysis
RM Bertina, NH Tilburg, NJ Fouw, F Haverkate |
Annals of the New York Academy of Sciences | 1992 |
Assignment of the human α2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids
SK Welch, U Francke |
Genomics | 1992 |
ECAT Assay Procedures A Manual of Laboratory Techniques
J Jespersen, RM Bertina, F Haverkate |
1992 | |
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
JL Heckel, EP Sandgren, JL Degen, RD Palmiter, RL Brinster |
Cell | 1990 |
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien |
1990 | |
Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence
O Miura, S Hirosawa, A Kato, N Aoki |
Journal of Clinical Investigation | 1989 |
Hemostasis associated with abnormalities of fibrinolysis
N Aoki |
Blood Reviews | 1989 |
Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin
C Kluft, AF Jie, P Los, E Wit, L Havekes |
Biochemical and Biophysical Research Communications | 1989 |
Hereditary α2-plasmin inhibitor deficiency caused by a transport-deficient mutation (α2-PI-Okinawa)
O Miura, Y Sugahara, N Aoki |
The Journal of biological chemistry | 1989 |
Clinical disorders of fibrinolysis: A critical review
RB Francis |
Blut Zeitschrift für die Gesamte Blutforschung | 1989 |
Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin
DC Rijken, E Groeneveld, C Kluft, HK Nieuwenhuis |
Biochemical Journal | 1988 |
The influence of thrombin and platelets on fibrin clot lysis rates in vitro: a study using a clot lysis system consisting of purified human proteins
NJ Fouw, YF Jong, F Haverkate, RM Bertina |
Fibrinolysis | 1988 |
α 2 -Antiplasmin Enschede: Alanine Insertion and Abolition of Plasmin Inhibitory Activity
WE Holmes, HR Lijnen, L Nelles, C Kluft, HK Nieuwenhuis, DC Rijken, D Collen |
Science | 1987 |